Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
about
HIV-1 envelope subregion length variation during disease progressionMutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.How does HIV-1 infect a susceptible human cell?: Current thinkingRelationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication.V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate.Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact.Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revertPeripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop.Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequencesInsertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration.Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor.Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infectionStructural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5.Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay.Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interactionEqual levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment.Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.
P2860
Q30397933-34B7CF23-6F1E-4ADE-9019-A01F704EFB2CQ30420728-D671E6B0-A7EA-47A9-963B-FE2CC9BB7DCCQ33782530-23284575-2CE9-45F3-AAF0-55F9687CA8E5Q34998032-F5B97BEB-9CDE-4F14-8ED8-38A108BC1B2DQ35217312-F05A8B7B-79EA-41CE-9AEC-7A15BCBFB60AQ35828735-3FED5618-E0B8-4C59-94ED-96D01A684DB9Q35830393-3BB050A3-EA72-4B26-9AA1-F96FC5FBD533Q35834804-80D42A46-AD85-46D3-B4E1-77D01CA149ADQ35837334-5E5B1021-6009-49FF-8052-50D0503ACD3BQ35838430-4046A382-EB2B-4F6E-9A82-974B6C3C94ADQ35846005-981D3517-A1A8-4589-99C6-B3947739EC6BQ35853972-5CC155ED-14B9-4C16-B44B-B9E673F3736BQ35868467-A7CE6625-2A10-4549-A997-A1B57BC2FB06Q36632356-2283D8AD-5F6F-45B0-A17E-EAC61828F7A4Q36635367-B37F7E9D-DE78-4168-A2BF-7D46BD482F59Q36636293-4C71A6CA-027C-4FC2-B14E-E2D9F852CCF0Q36637273-7D375165-020B-47DF-BE24-ADA8A66C7DE9Q36637380-6BCAF2EE-08E5-4171-846A-2B600A555107Q36676729-F28953D9-188E-4144-A74C-7FF1151399A3Q38943221-9C0235C9-0E31-4C89-9257-B419DBFB19AEQ39143639-6D69D7AE-7A9A-4A4C-93F8-A534D85D250AQ39193318-3EDDE3A2-55CC-4778-B18D-88AEAE4D3EB2Q39422872-FCAAE03F-9AAD-4C0C-957A-2B4EDF29A928Q39485924-D94BDCA3-06AA-461E-89FB-B2DC99A4F002Q39551157-F329ED5C-A11C-4D8C-BC1B-2A2E21250FADQ39601180-4410E813-368E-41E8-A880-DC511B194928Q39602915-E29D8EF6-FE0D-4FF9-ACF0-1F570D179D95Q39682713-77799452-05E1-4D78-8A66-6459F88C46F3Q39868495-66C91170-7854-4318-8E1C-04DB62B6D318Q39877884-1AB7CAFD-F3E7-42EC-86A6-4249E4D7FF14
P2860
Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Both the V2 and V3 regions of ...... egions in syncytium formation.
@ast
Both the V2 and V3 regions of ...... egions in syncytium formation.
@en
type
label
Both the V2 and V3 regions of ...... egions in syncytium formation.
@ast
Both the V2 and V3 regions of ...... egions in syncytium formation.
@en
prefLabel
Both the V2 and V3 regions of ...... egions in syncytium formation.
@ast
Both the V2 and V3 regions of ...... egions in syncytium formation.
@en
P2093
P2860
P1433
P1476
Both the V2 and V3 regions of ...... regions in syncytium formation
@en
P2093
Andeweg AC
Leeflang P
Osterhaus AD
P2860
P304
P407
P577
1993-06-01T00:00:00Z